D2C skincare brand Foxtale has successfully secured $30 million in its Series C funding round from KOSÉ Corporation, alongside current investors Panthera Growth Partners, Z47, and Kae Capital. The Mumbai-based company has formed a strategic alliance with the Japanese multinational firm KOSÉ Corporation, renowned for its cosmetics, beauty, and personal care products. This collaboration will see KOSÉ Corporation leverage Foxtale’s expertise in direct-to-consumer strategies and the Indian marketplace, while Foxtale will integrate KOSÉ’s cutting-edge technological capabilities in research and development for product innovation.
Kazutoshi Kobayashi, President and CEO of KOSÉ Corporation expressed satisfaction at the conclusion of a capital and strategic partnership with the rapidly growing Foxtale in the premium mass skincare sector, coinciding with the 10th anniversary of KOSÉ’s entry into the Indian market. He remarked that through this partnership, they will advance into the next decade with the aim of establishing a more significant presence in the Indian market and expanding their business.
The company intends to utilise this latest capital injection to reinforce its footprint in existing markets and boost its research and development efforts. Romita Mazumdar, Founder of Foxtale, highlighted that the funding from KOSÉ Corporation would facilitate faster scaling, deeper innovation, and the delivery of effective and accessible skincare solutions to a broader audience across India. She noted that beyond growth, this partnership represents a step towards fostering stronger global relationships, marrying international expertise with local insights.
Established in 2021, Foxtale has experienced more than a twofold growth in FY25 and is on track to achieve profitability by the end of the upcoming financial year. The company is in competition with other D2C brands such as Conscious Chemist, Dot & Key, and Aqualogica, in addition to established brands from legacy FMCG players.
